Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice (Q28378340)

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

[Serum creatinine determination without protein precipitation]

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Dosing and side-effects of ifosfamide plus mesna

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Comparative activity of ifosfamide and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

The influence of ifosfamide scheduling on acute nephrotoxicity in children

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Drug Interaction Effects on Antitumour Drugs (VIII): Prevention of Ifosfamide-Induced Urotoxicity by Disulfiram and its Effect on Antitumour Activity and Acute Toxicity of Alkylating Agents in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Modulatory effects of Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Spectrophotometric and kinetics investigation of the Berthelot reaction for the determination of ammonia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Ifosfamide, Fanconi's syndrome, and rickets

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Synovial sarcoma. Uniform response of metastases to high dose ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Antitumour principles from Nigella sativa seeds

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Ifosfamide, mesna, and nephrotoxicity in children

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Determination of blood glucose using 4-amino phenazone as oxygen acceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Determination of malonaldehyde precursor in tissues by thiobarbituric acid test

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

Ifosfamide metabolite chloroacetaldehyde causes Fanconi syndrome in the perfused rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2898%2900242-6

7 January 2021

10.1016/S0378-8741(98)00242-6

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

10619376

1 reference

Consolidated OpenCitations Corpus – April 2017